Plasma turnover in patients with COVID-19 disease and invasive mechanical ventilation: a randomized study - REP-COVID

Fundació Clínic per a la recerca Biomèdica0 个研究点目标入组 116 人开始时间: 2020年4月27日最近更新: 2023年9月26日

试验速览

暂无简介。

•1-Age 18-79 years;
•2-Diagnosis of COVID-19 by PCR in nasopharyngeal, sputum or bronchial aspirate smears :
•3-Admission to ICU with invasive mechanical ventilation;
•4-Telephone informed consent granted by family members or legal representative.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 91
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range 25

•1-> 7 days of invasive mechanical ventilation, 2- Refractory shock (norepinephrine> 0.5 microg / Kg / min), 3- Decompensated liver cirrhosis 4- Chronic hemodialysis 5- Active neoplastic disease 6- Moderate or severe heart failure (NYHA III- IV), 7- Moderate-severe lung disease (GOLD III-IV), 8- HIV with AIDS criteria.

发起方

Fundació Clínic per a la recerca Biomèdica